Colgate-Palmolive Company (CL)
3 Consumer Staples Stocks to Buy Before the End of June
Consumer confidence is softening into the back half of spring, and the rotation out of growth and into recession-resistant cash flow is picking up speed.
Colgate-Palmolive Company (CL) Presents at 23rd annual dbAccess Global Consumer Conference Transcript
Colgate-Palmolive Company (CL) Presents at 23rd annual dbAccess Global Consumer Conference Transcript
Is Colgate Too Dependent on Pricing Actions for Revenue Growth?
CL balances pricing and volume growth as emerging markets and innovation support sales momentum.
Why Colgate's Innovation Strategy Is Fueling Market Share Gains
CL's innovation strategy is driving market share gains as premium launches, pricing and science-based products support growth across oral care and pet nutrition.
Prediction: Colgate-Palmolive Will Jump 20% This Year
Colgate-Palmolive (NYSE:CL | CL Price Prediction) is exactly the kind of name investors hunt for when the macro picture gets murky.
Colgate-Palmolive: A Resilient Dividend King Navigating A Tougher Environment
Colgate-Palmolive remains a Buy, supported by resilient fundamentals, an attractive and still sustainable dividend yield while they hold the Dividend King status, and prudent valuation amid macro and geopolitical headwinds. CL posted solid Q1 results, with 8.4% net sales growth, robust free cash flow, and reaffirmed 2026 sales and EPS growth guidance despite Iran-driven margin pressures. Rising input and logistics costs, driven by the Iran conflict, are expected to pressure gross margins, but CL's strong cash flows support ongoing shareholder returns.
Colgate Q1 Earnings & Sales Beat Estimates on Pricing & Volume Growth
CL beats Q1 earnings estimates as pricing and volume lift sales 8.4%; costs and SGPP charges weigh on margins, but outlook stays intact.
Colgate-Palmolive Company (CL) Q1 2026 Earnings Call Transcript
Colgate-Palmolive Company (CL) Q1 2026 Earnings Call Transcript
Compared to Estimates, Colgate-Palmolive (CL) Q1 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Colgate-Palmolive (CL) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Colgate-Palmolive (CL) Beats Q1 Earnings and Revenue Estimates
Colgate-Palmolive (CL) came out with quarterly earnings of $0.97 per share, beating the Zacks Consensus Estimate of $0.95 per share. This compares to earnings of $0.91 per share a year ago.
Colgate-Palmolive Sales Rise on International Growth
The maker of consumer products, including toothpaste, deodorant and soap, posted net income of $646 million, or 80 cents a share, down from $690 million, or 85 cents a share, the year prior.
Procter & Gamble's Portfolio Strategy: Strengthening Core Brands?
PG's innovation-led strategy drives growth, with strong product launches, brand gains and supply chain upgrades reinforcing long-term competitive advantage.
